UK Markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
32.17-0.14 (-0.42%)
As of 2:56PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 515.21B
Enterprise value 320.68B
Trailing P/E N/A
Forward P/E 124.56
PEG ratio (5-yr expected) 14.38
Price/sales (ttm)4.65
Price/book (mrq)1.79
Enterprise value/revenue 36.32
Enterprise value/EBITDA 741.76

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 334.81
52-week low 318.37
50-day moving average 331.18
200-day moving average 330.36

Share statistics

Avg vol (3-month) 34.11M
Avg vol (10-day) 34.96M
Shares outstanding 5472.8M
Implied shares outstanding 6N/A
Float 424.82M
% held by insiders 14.20%
% held by institutions 199.19%
Shares short (14 Apr 2021) 410.22M
Short ratio (14 Apr 2021) 42.3
Short % of float (14 Apr 2021) 42.30%
Short % of shares outstanding (14 Apr 2021) 42.16%
Shares short (prior month 14 Mar 2021) 410.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -17.11%
Operating margin (ttm)0.41%

Management effectiveness

Return on assets (ttm)0.06%
Return on equity (ttm)-7.99%

Income statement

Revenue (ttm)3.27B
Revenue per share (ttm)7.42
Quarterly revenue growth (yoy)44.80%
Gross profit (ttm)1.7B
EBITDA 495.2M
Net income avi to common (ttm)-560.1M
Diluted EPS (ttm)-1.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)494.7M
Total cash per share (mrq)1.05
Total debt (mrq)6.39B
Total debt/equity (mrq)75.40
Current ratio (mrq)1.64
Book value per share (mrq)17.96

Cash flow statement

Operating cash flow (ttm)-41M
Levered free cash flow (ttm)187.5k